Title: Improved Overall Survival with Gemtuzumab Ozogamicin (GO) Compared with Best Supportive Care (BSC) in Elderly Patients with Untreated Acute Myeloid Leukemia (AML) Not Considered Fit for Intensive Chemotherapy: Final Results from the Randomized Phase III Study (AML-19) of the EORTC and Gimema Leukemia Groups
Authors: Amadori, Sergio
Sucio, Stefan
Selleslag, Dominik
Rossetti, Elena
Gaidano, Gianluca
Musso, Maurizio
Annino, Luciana
Venditti, Adriano
Magro, Domenico
De Fabritiis, Paolo
Muus, Petra
Alimena, Giuliana
Mancini, Marco
Hagemeijer-Hausman, Ann
Cotugno, Francesca
Vignetti, Marco
Fazi, Paola
Meert, Liv
Ramadan, Safaa M
Willemze, Roelof
de Witte, Theo
Baron, Frederic
Issue Date: Dec-2014
Publisher: W.B. Saunders
Host Document: Blood vol:124 issue:21 pages:(oral abstract)
Conference: 56th ASH Annual Meeting & Exposition location:San Francisco, CA, USA date:December 6-9, 2014
Article number: 619
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Department of Human Genetics - miscellaneous

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.